Physician profile
Charles Wolff
NPI 1407875966
$9,197.07
in general payments reported to CMS, 2019-2025
43 companies · $765 in 2025
The $765 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,440 · 2020: $198 · 2021: $356 · 2022: $278 · 2023: $820 · 2024: $341 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320 · Travel and Lodging: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,319.97 |
| Travel and Lodging | $605.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes USA Products LLC | $3,951.64 | 2019 | |
| Crossroads Extremity Systems, LLC | $993.34 | 2019 | |
| Biomedical Enterprises, INC. | $984.74 | 2019 | |
| International Life Sciences | $605.60 | 2023 | |
| Smith+Nephew, INC. | $276.52 | 2019-2025 | Grafix Pl, Bone Anchors With Arthroscopic Delivery System, Stravix Pl |
| Stryker Corporation | $242.90 | 2019-2021 | |
| Treace Medical Concepts, INC. | $229.61 | 2022-2025 | |
| Paragon 28, INC. | $174.88 | 2021-2025 | Precision Mis Bunion |
| Integra Lifesciences Corporation | $149.46 | 2019-2020 | |
| Heron Therapeutics, INC. | $144.29 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $105.68 | 2022-2025 | Nuzyra |
| Tenex Health INC. | $99.38 | 2021 | |
| Organogenesis INC. | $87.56 | 2021-2025 | Apligraf |
| Celularity INC. | $86.00 | 2019 | |
| Horizon Therapeutics Plc | $75.92 | 2019-2020 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $71.61 | 2023-2024 | Theragenesis Wound Matrix |
| Depuy Synthes Sales INC. | $70.08 | 2019-2024 | Motoband |
| Curonix LLC | $69.38 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $65.79 | 2025 | Krystexxa |
| Dynasplint Systems INC. | $58.44 | 2022 | |
| Bone Support INC. | $46.62 | 2025 | Ceramentbone Void Filler, Cerament G |
| Highridge Medical LLC | $46.16 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $46.16 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Nevro Corp. | $45.49 | 2022 | |
| Assertio Therapeutics, INC. | $41.73 | 2020 | |
| Tactile Systems Technology INC | $38.21 | 2024 | Entre Plus, Flexitouch Plus |
| Ethicon US, LLC | $34.26 | 2025 | Dermabond |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.17 | 2019-2021 | |
| Abbott Laboratories | $30.99 | 2023-2025 | Proclaim, Eterna |
| Zyla Life Sciences, INC. | $29.92 | 2020 | |
| Urgo Medical North America, LLC | $25.80 | 2024 | Urgoclean Ag |
| Abbvie INC. | $23.95 | 2024 | |
| Medtronic, INC. | $23.81 | 2022 | |
| Ibsa Pharma INC. | $23.64 | 2023 | Licart, Tirosint |
| Bioventus LLC | $23.27 | 2023 | |
| Ani Pharmaceuticals, INC. | $20.91 | 2023 | Purified Cortrophin Gel |
| Solventum Corporation | $19.96 | 2025 | V.A.C. Dermatac, Activ.A.C., Promogran Prisma |
| Wright Medical Technology, INC. | $19.93 | 2019 | |
| Next Science LLC | $19.92 | 2023 | Surgx, Blastx, Xperience |
| Kerecis Limited | $17.98 | 2021 | |
| Reprise Biomedical, INC. | $17.45 | 2024 | Miro3d |
| Hydrofera LLC | $16.34 | 2024 | Cutimed Sorbion |
| Orthofix Medical, INC. | $10.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.